Adenovirus Vector Vaccine Market Projected to Show Strong Growth
Author : Lal Singh Bisht | Published On : 28 Dec 2023
The Latest research coverage on Adenovirus Vector Vaccine Market provides a detailed overview and accurate market size. The study is designed considering current and historical trends, market development and business strategies taken up by leaders and new industry players entering the market. Furthermore, study includes an in-depth analysis of global and regional markets along with country level market size breakdown to identify potential gaps and opportunities to better investigate market status, development activity, value and growth patterns.
Access Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/165891-global-adenovirus-vector-vaccine-market
Major & Emerging Players in Adenovirus Vector Vaccine Market:-
Creative Biolabs (United States), Sartorius AG (Germany), Lonza (Switzerland), Merck KGaA (Germany), Cobra Biologics (United States), Thermo Fisher Scientific (United States), Boehringer Ingelheim (Germany), Oxford Biomedica (United Kingdom), Advanced Bioscience Laboratories (United States).
The Adenovirus Vector Vaccine Market Study by AMA Research gives an essential tool and source to Industry stakeholders to figure out the market and other fundamental technicalities, covering growth, opportunities, competitive scenarios, and key trends in the Adenovirus Vector Vaccine market.
Adenovirus represents the class of the genetically diverse DNA viruses that can cause non-life-threatening infections related to eyes, respiratory system, gastrointestinal lining and other parts. These viruses represent promising results as a vector for delivering target antigens to various hosts due to excellent ability induce immune response. Due to these property, the new studies concluded positive results for use of adenovirus for both gene therapy and vaccine production. Adenovirus-based vectors shows various benefits when compared to other viral vectors such as wide range of tissue tropism, ease of genetic manipulation especially for large transgene DNA insertions, superior ability to induce robust transgene-specific T cell and antibody responses, easy production of the adenovirus based vaccines at large scale. Due to this, it has emerged as a preferred choice for delivering vaccine for both humans as well as animals.
In February 2021, the Janssen Biotech, a part of Johnson and Johnson submitted Emergency Use Authorization (EUA) to the US Food and Drug Administration (FDA), for its investigational single-dose coronavirus 2019 (COVID-19) vaccine candidate. The vaccine Ad26.COV2.S, is a recombinant, replication-incompetent adenovirus serotype 26 (Ad26) vector encoding a full-length and stabilized SARS-CoV-2 spike (S) protein
In January 2021, Thermo Fisher Scientific, a company offering range of instrumentation, reagents and consumables, and software and services acquired the viral-vector manufacturing business of the Novasep, a pharmaceutical company for approximately USD 875 million in cash. This acquisition is a step towards expanding Thermo Fisher capabilities in the cell and gene vaccines and therapies worldwide.
The titled segments and sub-section of the market are illuminated below: by Type (Adenovirus-based tuberculosis vaccine, Adenovirus-based HIV vaccine, Adenovirus-based influenza vaccine, Others), Application (Human, Animals), End-user (Hospitals, Ambulatory Surgical Center, Research Institutes, Others)
Market Trends:
Increasing investment in vaccine and drug development
Rising collaboration between the pharmaceutical companies and CROs for development of adenovirus vector vaccine
Opportunities:
Emergence of adenovirus vectored vaccines for COVID-19
Production of low cost adenovirus vaccines
Market Drivers:
Growing prevalence of chronic medical conditions
Rise in demand for efficient vaccines to treat infectious diseases
Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/165891-global-adenovirus-vector-vaccine-market
Some Point of Table of Content:
Chapter One: Report Overview
Chapter Two: Global Market Growth Trends
Chapter Three: Value Chain of Adenovirus Vector Vaccine Market
Chapter Four: Players Profiles
Chapter Five: Global Adenovirus Vector Vaccine Market Analysis by Regions
Chapter Six: North America Adenovirus Vector Vaccine Market Analysis by Countries
Chapter Seven: Europe Adenovirus Vector Vaccine Market Analysis by Countries
Chapter Eight: Asia-Pacific Adenovirus Vector Vaccine Market Analysis by Countries
Chapter Nine: Middle East and Africa Adenovirus Vector Vaccine Market Analysis by Countries
Chapter Ten: South America Adenovirus Vector Vaccine Market Analysis by Countries
Chapter Eleven: Global Adenovirus Vector Vaccine Market Segment by Types
Chapter Twelve: Global Adenovirus Vector Vaccine Market Segment by Applications
What are the market factors that are explained in the Adenovirus Vector Vaccine Market report?
– Key Strategic Developments: Strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors.
– Key Market Features: Including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin.
– Analytical Tools: The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.
Buy This Exclusive Research Here: https://www.advancemarketanalytics.com/buy-now?format=1&report=165891
Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Contact US :
Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 201 565 3262, +44 161 818 8166
sales@advancemarketanalytics.com
